Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more
Foundayo, a new obesity pill made by Eli Lilly, was recently approved by the Food and Drug Administration. Eli Lilly hide caption caption letter Eli Lilly The Food and Drug Administration has approved a second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day … Read more
The US Food and Drug Administration on Wednesday approved a second GLP-1 pill for weight loss, adding another option to its rapidly growing arsenal of obesity therapies. The orforglipron pill, called Foundayo, is made by Eli Lilly, which also sells the GLP-1 drugs Zepbound for obesity and Mounjaro for diabetes. It is given as a … Read more
The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more
The second quarter is looking very busy for the FDA, which in April is expected to make a handful of very important decisions. One of them is for a rare disease with unmet needs, while the other, for the treatment of melanoma, can be a sign of how things can change in the institution after … Read more